AGNISTA Trademark

Trademark Overview

On Tuesday, November 10, 2020, a trademark application was filed for AGNISTA with the United States Patent and Trademark Office. The USPTO has given the AGNISTA trademark a serial number of 90311132. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 21, 2022. This trademark is owned by Agnista Therapeutics Inc.. The AGNISTA trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Biological preparations for the treatment of cancer; Biological preparations for the treatment of inflammatory diseases, disorders and conditions; Biological preparations for the treatment of immune related diseases, disorders and conditions; Pharmaceutical preparations for the treatment of immune related diseases, disorders and conditions; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of inflammatory diseases, disorders and conditions

Licensing of intellectual property; Licensing of intellectual property in the field of pharmaceuticals; Licensing of intellectual property in the field of medical and scientific technologies

Clinical research in the field of immune related diseases, disorders and conditions; Clinical research in the field of tumors, malignancies, and related diseases, disorders and conditions; Clinical research in the field of inflammatory diseases, disorders and conditions; Development of pharmaceutical preparations and medicines; Medical research; Medical and scientific research in the field of inflammatory diseases and cancer treatment and diagnosis; Medical and scientific research in the field of immune related diseases, disorders and conditions; Medical and scientific research in the field of tumors, malignancies, and related diseases, disorders and conditions; Pharmaceutical products development; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research and development
agnista

General Information

Serial Number90311132
Word MarkAGNISTA
Filing DateTuesday, November 10, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 21, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 25, 2021

Trademark Statements

Goods and ServicesBiological preparations for the treatment of cancer; Biological preparations for the treatment of inflammatory diseases, disorders and conditions; Biological preparations for the treatment of immune related diseases, disorders and conditions; Pharmaceutical preparations for the treatment of immune related diseases, disorders and conditions; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of inflammatory diseases, disorders and conditions
Goods and ServicesLicensing of intellectual property; Licensing of intellectual property in the field of pharmaceuticals; Licensing of intellectual property in the field of medical and scientific technologies
Goods and ServicesClinical research in the field of immune related diseases, disorders and conditions; Clinical research in the field of tumors, malignancies, and related diseases, disorders and conditions; Clinical research in the field of inflammatory diseases, disorders and conditions; Development of pharmaceutical preparations and medicines; Medical research; Medical and scientific research in the field of inflammatory diseases and cancer treatment and diagnosis; Medical and scientific research in the field of immune related diseases, disorders and conditions; Medical and scientific research in the field of tumors, malignancies, and related diseases, disorders and conditions; Pharmaceutical products development; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research and development

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, January 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, January 10, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, January 10, 2021
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAgnista Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306
Party NameAgnista Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306

Trademark Events

Event DateEvent Description
Tuesday, February 22, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 21, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 20, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 25, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 25, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 5, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 17, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 17, 2021ASSIGNED TO EXAMINER
Sunday, January 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 13, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

agnista diseases research disorders conditions field treatment preparations medical pharmaceutical scientific